(Q44481918)

3 December 2017

title

Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum beta-lactamases isolated in Japan (English)

1 reference

3 December 2017

0 references

Masaru Komatsu

1

1 reference

3 December 2017

Masanori Aihara

2

1 reference

3 December 2017

Kouichi Shimakawa

3

1 reference

3 December 2017

Mizuho Iwasaki

4

1 reference

3 December 2017

Yoko Nagasaka

5

1 reference

3 December 2017

Saori Fukuda

6

1 reference

3 December 2017

Shuji Matsuo

7

1 reference

3 December 2017

Yoshinori Iwatani

8

1 reference

3 December 2017

publication date

1 June 2003

1 reference

Diagnostic Microbiology and Infectious Disease

3 December 2017

published in

1 reference

3 December 2017

volume

46

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

125-130

1 reference

Comparative activity of cefotetan on Escherichia coli K12 possessing plasmid-mediated beta-lactamases

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Treatment failure due to extended spectrum beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

[Extended-spectrum beta-lactamase (ESBL) produced by Escherichia coli and Klebsiella pneumoniae isolated from Teikyou University Hospital--the first report].

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Hospital outbreak of MEN-1-derived extended spectrum beta-lactamase-producing Klebsiella pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

In vitro evaluation of cefepime and other broad-spectrum beta-lactams in 22 medical centers in Japan: a phase II trial comparing two annual organism samples. The Japan Antimicrobial Resistance Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

The use of analytical isoelectric focusing for detection and identification of beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

[A SHV-derived extended-spectrum beta-lactamase (SHV-12) produced by an Escherichia coli recovered from wound abscess in post operative case with rectal carcinoma]

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Characterization of beta-lactamases in situ on polyacrylamide gels

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like beta-lactamase genes

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

Production of CTX-M-3 extended-spectrum beta-lactamase and IMP-1 metallo beta-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900041-5

7 January 2021

10.1016/S0732-8893(03)00041-5

Identifiers

DOI

1 reference

3 December 2017

1 reference